期刊文献+

三阴性乳腺癌的临床特点及研究进展 被引量:4

原文传递
导出
摘要 乳腺癌是一种高度异质性的恶性肿瘤,全世界每年约有41万女性死于乳腺癌。1983年全国乳腺癌协会将乳腺癌分为非浸润性癌、早期浸润性癌、浸润性特殊癌和浸润性非特殊癌4大类。近年来,雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2)已成为乳腺癌患者免疫组化标志物常规检查项目。三阴性乳腺癌为ER、PR、HER-2均为阴性的乳腺癌。
出处 《中国肿瘤临床与康复》 2014年第5期636-638,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 三阴性乳腺癌 治疗 进展 Triple-negative breast cancer Treatment Progress
  • 相关文献

参考文献14

  • 1Rakha EA,Ellis IO.Triple-negative/basal-like breast cancer:review[J].Pathology,2009,41:40-47.
  • 2Irvin WJ Jr,Carey LA.What is triple-negative breast cancer?[J].Eur J Cancer,2008,44:2799-2805.
  • 3Benueei F.How basal are triple-negative breast cancer[J].Int J Cancer,2008,123:236-240.
  • 4Cleator S,Heller W,Coombes RC.Triple negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8:235-244.
  • 5Siziopkou KP,Cobleigh M.The basal subtype of breast carcinomasmay represent the group of breast tumors that could benefit from EGFR-targeted therapies[J].Breast,2007,16:104-106.
  • 6Lin NU,Caus E,Sohl J,et al.Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer:high incidence of central nervous system metastases[J].Cancer,2008,113:2638-2640.
  • 7Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13:4429-4434.
  • 8Knigsberg R,Pfeiler G,Kurzawa R,et al.Prognostic assessment and adjuvant treatment strategies within early-stage,sporadic triple negative breast cancer patients[J].Cancer Invest,2011,29:180-186.
  • 9Staudacher L,Cottu PH,Dieras V,et al.Platinum-based chemotherapy in metastatic triple-negative breast cancer,the institut curie experience[J].Ann Oncol,2011,22:848-856.
  • 10吴立新,黄玉霞,方月兰,夏国安.吉西他滨联合顺铂二线治疗晚期三阴乳腺癌的临床观察[J].安徽医药,2011,15(9):1149-1150. 被引量:17

二级参考文献6

  • 1Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)negative,progesterone receptor(PR)negative,and HER-2 negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer,2007,109(9):1721.
  • 2Yi S,Uhm J,Cho E,et al.Clinical outcomes of metastatic breast cancer patients with triple-negative phenotype who received platinum-containing chemotherapy[J].J Clin Oncol,2008,26:1008.
  • 3Miller K,Wang M,Gralow J,et al.Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer[J].N Engl J Med,2007,357(26):2666-76.
  • 4Zelek L,Barthier S,Riofrio M,et al.Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma[J].Cancer,2001,92(9):2267-72.
  • 5Decatris MP,Sunder S,O Byrne KJ,et al.Platinum-based chemotherapy in metastatic breast cancer:current status[J].Cancer Trert Rev,2004,30(1):53-81.
  • 6周际昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,2005:92-94.

共引文献16

同被引文献35

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部